{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:35:30Z","timestamp":1791570930063,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100740"],"award-info":[{"award-number":["82100740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170715"],"award-info":[{"award-number":["82170715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science Foundation of Fujian Province of China","award":["2021J05154"],"award-info":[{"award-number":["2021J05154"]}]},{"name":"Science and Technology Development Fund of Shanghai Pudong New Area","award":["PKJ2021-Y37"],"award-info":[{"award-number":["PKJ2021-Y37"]}]},{"name":"Talents Training Program of Pudong Hospital affiliated to Fudan University","award":["LJ202201"],"award-info":[{"award-number":["LJ202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01714-5","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:54:39Z","timestamp":1741780479000},"page":"3341-3351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["sPLA2-IB and PLA2R Mediate Aberrant Glucose Metabolism in Podocytes via Hyperactivation of the mTOR\/HIF-1\u03b1 Pathway"],"prefix":"10.1007","volume":"83","author":[{"given":"Jiwen","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-med-050522-034537","volume":"75","author":"R Avasare","year":"2023","unstructured":"Avasare, R., Andeen, N. & Beck, L. (2023). Novel antigens and clinical updates in membranous nephropathy. Annual Review of Medicine, 75, 219\u2013332.","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"1714_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12035-013-8565-9","volume":"49","author":"T Yagami","year":"2014","unstructured":"Yagami, T., Yamamoto, Y., & Koma, H. (2014). The role of secretory phospholipase a(2) in the central nervous system and neurological diseases. Molecular Neurobiology, 49(2), 863\u2013876.","journal-title":"Molecular Neurobiology"},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cca.2018.04.009","volume":"482","author":"W Li","year":"2018","unstructured":"Li, W., Zhang, M., Guo, Y., Liu, X., Ji, X., Su, J., Zhang, Z., & Zhang, F. (2018). Serum secretory phospholipase a2 group ib correlates with the severity of membranous nephropathy. Clinica Chimica Acta, 482, 178\u2013184.","journal-title":"Clinica Chimica Acta"},{"key":"1714_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep06660","volume":"4","author":"Y Pan","year":"2014","unstructured":"Pan, Y., Wan, J., Liu, Y., Yang, Q., Liang, W., Singhal, P. C., Saleem, M. A., & Ding, G. (2014). Spla2 ib induces human podocyte apoptosis via the m-type phospholipase a2 receptor. Scientific Reports, 4, 6660.","journal-title":"Scientific Reports"},{"issue":"5","key":"1714_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41419-020-2481-5","volume":"11","author":"Q Yuan","year":"2020","unstructured":"Yuan, Q., Miao, J., Yang, Q., Fang, L., Fang, Y., Ding, H., Zhou, Y., Jiang, L., Dai, C., Zen, K., Sun, Q., & Yang, J. (2020). Role of pyruvate kinase m2-mediated metabolic reprogramming during podocyte differentiation. Cell Death & Disease, 11(5), 355.","journal-title":"Cell Death & Disease"},{"issue":"1","key":"1714_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J. X., Wang, Z., & Yu, T. (2022). Lactate metabolism in human health and disease. Signal Transduction and Targeted Therapy, 7(1), 305.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"1714_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I., & Chandel, N. S. (2020). Mitochondrial tca cycle metabolites control physiology and disease. Nature Communications, 11(1), 102.","journal-title":"Nature Communications"},{"issue":"5930","key":"1714_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"HM Vander","year":"2009","unstructured":"Vander, H. M., Cantley, L. C., & Thompson, C. B. (2009). Understanding the warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930), 1029\u20131033.","journal-title":"Science"},{"key":"1714_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s42003-018-0200-x","volume":"1","author":"C Podrini","year":"2018","unstructured":"Podrini, C., Rowe, I., Pagliarini, R., Costa, A., Chiaravalli, M., Di Meo, I., Kim, H., Distefano, G., Tiranti, V., Qian, F., di Bernardo, D., Frezza, C., & Boletta, A. (2018). Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways. Communications Biology, 1, 194.","journal-title":"Communications Biology"},{"issue":"15","key":"1714_CR10","doi-asserted-by":"publisher","first-page":"e86976","DOI":"10.1172\/jci.insight.86976","volume":"1","author":"KM Sas","year":"2016","unstructured":"Sas, K. M., Kayampilly, P., Byun, J., Nair, V., Hinder, L. M., Hur, J., Zhang, H., Lin, C., Qi, N. R., Michailidis, G., Groop, P. H., Nelson, R. G., Darshi, M., Sharma, K., Schelling, J. R., Sedor, J. R., Pop-Busui, R., Weinberg, J. M., Soleimanpour, S. A., & Pennathur, S. (2016). Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. Jci Insight, 1(15), e86976.","journal-title":"Jci Insight"},{"issue":"2","key":"1714_CR11","doi-asserted-by":"publisher","first-page":"e48781","DOI":"10.15252\/embr.201948781","volume":"21","author":"J Li","year":"2020","unstructured":"Li, J., Sun, Y., Chen, W., Fan, J., Li, S., Qu, X., Chen, Q., Chen, R., Zhu, D., Zhang, J., Wu, Z., Chi, H., Crawford, S., Oorschot, V., Puelles, V. G., Kerr, P. G., Ren, Y., Nilsson, S. K., Christian, M., & Yu, X. (2020). Smad4 promotes diabetic nephropathy by modulating glycolysis and oxphos. Embo Reports, 21(2), e48781.","journal-title":"Embo Reports"},{"issue":"2","key":"1714_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41581-022-00648-y","volume":"19","author":"C Huynh","year":"2023","unstructured":"Huynh, C., Ryu, J., Lee, J., Inoki, A., & Inoki, K. (2023). Nutrient-sensing mtorc1 and ampk pathways in chronic kidney diseases. Nature Reviews Nephrology, 19(2), 102\u2013122.","journal-title":"Nature Reviews Nephrology"},{"issue":"7","key":"1714_CR13","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/ijms19072043","volume":"19","author":"Z Mao","year":"2018","unstructured":"Mao, Z., & Zhang, W. (2018). Role of mtor in glucose and lipid metabolism. International Journal of Molecular Sciences, 19(7), 2043.","journal-title":"International Journal of Molecular Sciences"},{"issue":"14","key":"1714_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004). Rictor, a novel binding partner of mtor, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology, 14(14), 1296\u20131302.","journal-title":"Current Biology"},{"issue":"3","key":"1714_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed, A., Kim, E., & Jacinto, E. (2021). Regulation and metabolic functions of mtorc1 and mtorc2. Physiological Reviews, 101(3), 1371\u20131426.","journal-title":"Physiological Reviews"},{"issue":"2","key":"1714_CR16","doi-asserted-by":"publisher","first-page":"e21170","DOI":"10.1096\/fj.202001143R","volume":"35","author":"L Yang","year":"2021","unstructured":"Yang, L., Wu, Y., Lin, S., Dai, B., Chen, H., Tao, X., Li, G., Wan, J., & Pan, Y. (2021). Spla2-ib and pla2r mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38mapk\/mtor\/ulk1(ser757) signaling pathway. Faseb Journal, 35(2), e21170.","journal-title":"Faseb Journal"},{"key":"1714_CR17","doi-asserted-by":"publisher","first-page":"5497346","DOI":"10.1155\/2021\/5497346","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li, Y., Sha, Z., & Peng, H. (2021). Metabolic reprogramming in kidney diseases: evidence and therapeutic opportunities. International Journal of Nephrology, 2021, 5497346.","journal-title":"International Journal of Nephrology"},{"issue":"4","key":"1714_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s12079-023-00781-8","volume":"17","author":"M Ma","year":"2023","unstructured":"Ma, M., Pan, Y., Zhang, Y., Yang, M., Xi, Y., Lin, B., Hao, W., Liu, J., Wu, L., Liu, Y., & Qin, X. (2023). Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the ampk\/mtor signaling pathway. Journal of Cell Communication and Signaling, 17(4), 1405\u20131415.","journal-title":"Journal of Cell Communication and Signaling"},{"issue":"5","key":"1714_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/glia.23760","volume":"68","author":"Y Hu","year":"2020","unstructured":"Hu, Y., Mai, W., Chen, L., Cao, K., Zhang, B., Zhang, Z., Liu, Y., Lou, H., Duan, S., & Gao, Z. (2020). Mtor-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and atp. Glia, 68(5), 1031\u20131045.","journal-title":"Glia"},{"key":"1714_CR20","doi-asserted-by":"publisher","first-page":"112349","DOI":"10.1016\/j.biopha.2021.112349","volume":"144","author":"TT Chiou","year":"2021","unstructured":"Chiou, T. T., Chau, Y. Y., Chen, J. B., Hsu, H. H., Hung, S. P., & Lee, W. C. (2021). Rapamycin attenuates pla2r activation-mediated podocyte apoptosis via the pi3k\/akt\/mtor pathway. Biomedicine & Pharmacotherapy, 144, 112349.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"1714_CR21","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.3390\/ijms24098391","volume":"24","author":"SC Badoiu","year":"2023","unstructured":"Badoiu, S. C., Greabu, M., Miricescu, D., Stanescu-Spinu, I. I., Ilinca, R., Balan, D. G., Balcangiu-Stroescu, A. E., Mihai, D. A., Vacaroiu, I. A., Stefani, C., & Jinga, V. (2023). Pi3k\/akt\/mtor dysregulation and reprogramming metabolic pathways in renal cancer: crosstalk with the vhl\/hif axis. International Journal of Molecular Sciences, 24(9), 8391.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1714_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2019.03.005","volume":"512","author":"M Kang","year":"2019","unstructured":"Kang, M., Lee, S. M., Kim, W., Lee, K. H., & Kim, D. Y. (2019). Fubp1 supports the lactate-akt-mtor axis through the upregulation of hk1 and hk2. Biochemical and Biophysical Research Communications, 512(1), 93\u201399.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"1714_CR23","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/cells8121584","volume":"8","author":"C Magaway","year":"2019","unstructured":"Magaway, C., Kim, E., & Jacinto, E. (2019). Targeting mtor and metabolism in cancer: lessons and innovations. Cells, 8(12), 1584.","journal-title":"Cells"},{"issue":"4","key":"1714_CR24","doi-asserted-by":"publisher","first-page":"e13850","DOI":"10.1111\/apha.13850","volume":"235","author":"Q Ye","year":"2022","unstructured":"Ye, Q., Lan, B., Liu, H., Persson, P. B., Lai, E. Y., & Mao, J. (2022). A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies. Acta Physiologica, 235(4), e13850.","journal-title":"Acta Physiologica"},{"issue":"7","key":"1714_CR25","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/cells9071700","volume":"9","author":"J Blaine","year":"2020","unstructured":"Blaine, J., & Dylewski, J. (2020). Regulation of the actin cytoskeleton in podocytes. Cells, 9(7), 1700.","journal-title":"Cells"},{"issue":"6487","key":"1714_CR26","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020). Metabolic reprogramming and cancer progression. Science, 368(6487), eaaw5473.","journal-title":"Science"},{"issue":"17","key":"1714_CR27","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","volume":"23","author":"A Fukushi","year":"2022","unstructured":"Fukushi, A., Kim, H. D., Chang, Y. C., & Kim, C. H. (2022). Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells. International Journal of Molecular Sciences, 23(17), 10037.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6204","key":"1714_CR28","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H., Rao, N. A., Aghajanirefah, A., Manjeri, G. R., Li, Y., Ifrim, D. C., Arts, R. J., van der Veer, B. M., Deen, P. M., Logie, C., O\u2019Neill, L. A., Willems, P., & Netea, M. G. (2014). Mtor- and hif-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345(6204), 1250684.","journal-title":"Science"},{"issue":"1","key":"1714_CR29","doi-asserted-by":"publisher","first-page":"2251234","DOI":"10.1080\/13510002.2023.2251234","volume":"28","author":"KH Xue","year":"2023","unstructured":"Xue, K. H., Jiang, Y. F., Bai, J. Y., Zhang, D. Z., Chen, Y. H., Ma, J. B., Zhu, Z. J., Wang, X., & Guo, P. (2023). Melatonin suppresses akt\/mtor\/s6k activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing warburg effect. Redox Report, 28(1), 2251234.","journal-title":"Redox Report"},{"key":"1714_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.metabol.2018.11.010","volume":"91","author":"M Yan","year":"2019","unstructured":"Yan, M., Qi, H., Xia, T., Zhao, X., Wang, W., Wang, Z., Lu, C., Ning, Z., Chen, H., Li, T., Tekcham, D. S., Liu, X., Liu, J., Chen, D., Liu, X., Xu, G., & Piao, H. L. (2019). Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing ampkalpha. Metabolism-Clinical and Experimental, 91, 18\u201329.","journal-title":"Metabolism-Clinical and Experimental"},{"issue":"2","key":"1714_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1681\/ASN.2013121315","volume":"26","author":"L Kao","year":"2015","unstructured":"Kao, L., Lam, V., Waldman, M., Glassock, R. J., & Zhu, Q. (2015). Identification of the immunodominant epitope region in phospholipase a2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. Journal of the American Society of Nephrology, 26(2), 291\u2013301.","journal-title":"Journal of the American Society of Nephrology"},{"key":"1714_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0090-6980(02)00022-9","volume":"68-69","author":"K Hanasaki","year":"2002","unstructured":"Hanasaki, K., & Arita, H. (2002). Phospholipase a2 receptor: a regulator of biological functions of secretory phospholipase a2. Prostaglandins & Other Lipid Mediators, 68-69, 71\u201382.","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"1","key":"1714_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/REP-08-0209","volume":"137","author":"I Woclawek-Potocka","year":"2009","unstructured":"Woclawek-Potocka, I., Komiyama, J., Saulnier-Blache, J. S., Brzezicka, E., Bah, M. M., Okuda, K., & Skarzynski, D. J. (2009). Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus. Reproduction, 137(1), 95\u2013105.","journal-title":"Reproduction"},{"issue":"6","key":"1714_CR34","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1021\/bi062119b","volume":"46","author":"M Rouault","year":"2007","unstructured":"Rouault, M., Le Calvez, C., Boilard, E., Surrel, F., Singer, A., Ghomashchi, F., Bezzine, S., Scarzello, S., Bollinger, J., Gelb, M. H., & Lambeau, G. (2007). Recombinant production and properties of binding of the full set of mouse secreted phospholipases a2 to the mouse m-type receptor. Biochemistry, 46(6), 1647\u20131662.","journal-title":"Biochemistry"},{"issue":"8","key":"1714_CR35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1248\/bpb.27.1165","volume":"27","author":"K Hanasaki","year":"2004","unstructured":"Hanasaki, K. (2004). Mammalian phospholipase a2: phospholipase a2 receptor. Biological & Pharmaceutical Bulletin, 27(8), 1165\u20131167.","journal-title":"Biological & Pharmaceutical Bulletin"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01714-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:22:36Z","timestamp":1757146956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01714-5","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"27 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}